5TO K K, HUNG 1 F, LI L W, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic Ht Nl 2009 influenza virus infection [ J]. Clin Infect Dis, 2010, 50(6) : 850 -859.
6NQUYEN H T, TRUJILLO A A, SI-IEU T G, et al. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States[J]. Antivira Res, 2012, 93(3): 381 -386.
7LUKE T C, KILBANE E M, JACKSON J L, et al. Meta- analy- sis: convalescent blood products for spanish influenza pneumonia: a future HsN1 treatment? [J]. Ann Intern Med, 2006, 145(8) : 599 - 609.
8HUNG I F, TO K K, LEE C K, et al. Convalescent plasma trent- ment reduced mortality in patients with severe pandemic influenza A(H5N1)2009 virus infection[J]. Clin Infect Dis, 2011, 52 (4) : 447 -456.
9AOKI F Y, HAYDEN F G, DOLIN R. Antiviral drugs ( other than antiretrovirals) [ M]// MANDELL G L, BENNETT J E, DOLIN R, et al. Principlesand Practices of Infectious Diseases. 7th ed. New York: Churchill Livingstone Elsevier, 2009.
10CHAN K H, TO K K, HUNG I F, et al. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1 N1 2009 influenza [ J]. Clin Vaccine Immu- nol, 2011, 18(5) : 865' -873.
